Stock Research for GTXI

GTXI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

GTXI Stock Chart & Research Data

The GTXI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GTXI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GTXI Due diligence Resources & Stock Charts

The GTXI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GTXI Detailed Price Forecast - CNN Money CNN View GTXI Detailed Summary - Google Finance
Yahoo View GTXI Detailed Summary - Yahoo! Finance Zacks View GTXI Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View GTXI Trends & Analysis - Trade-Ideas Barrons View GTXI Major Holders - Barrons
NASDAQ View GTXI Call Transcripts - NASDAQ Seeking View GTXI Breaking News & Analysis - Seeking Alpha
Spotlight View GTXI Annual Report - CompanySpotlight.com OTC Report View GTXI OTC Short Report - OTCShortReport.com
TradeKing View GTXI Fundamentals - TradeKing Charts View GTXI SEC Filings - Bar Chart
WSJ View Historical Prices for GTXI - The WSJ Morningstar View Performance/Total Return for GTXI - Morningstar
MarketWatch View the Analyst Estimates for GTXI - MarketWatch CNBC View the Earnings History for GTXI - CNBC
StockMarketWatch View the GTXI Earnings - StockMarketWatch MacroAxis View GTXI Buy or Sell Recommendations - MacroAxis
Bullish View the GTXI Bullish Patterns - American Bulls Short Pains View GTXI Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View GTXI Stock Mentions - StockTwits PennyStocks View GTXI Stock Mentions - PennyStockTweets
Twitter View GTXI Stock Mentions - Twitter Invest Hub View GTXI Investment Forum News - Investor Hub
Yahoo View GTXI Stock Mentions - Yahoo! Message Board Seeking Alpha View GTXI Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for GTXI - SECform4.com Insider Cow View Insider Transactions for GTXI - Insider Cow
CNBC View GTXI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GTXI - OTC Markets
Yahoo View Insider Transactions for GTXI - Yahoo! Finance NASDAQ View Institutional Holdings for GTXI - NASDAQ


Stock Charts

FinViz View GTXI Stock Insight & Charts - FinViz.com StockCharts View GTXI Investment Charts - StockCharts.com
BarChart View GTXI Stock Overview & Charts - BarChart Trading View View GTXI User Generated Charts - Trading View


Latest Financial News for GTXI

Detailed Research: Economic Perspectives on First Mid-Illinois Bancshares, GTx, Ferroglobe, SunOpta, Bandwidth, and Carbonite — What Drives Growth in Today's Competitive Landscape
Posted on Tuesday June 05, 2018

NEW YORK, June 05, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of First ...


GTx, Inc. to Participate in the Jefferies 2018 Global Healthcare Conference
Posted on Thursday May 31, 2018

GTx, Inc. today announced that Robert J. Wills, PhD, Executive Chairman, will present a company overview at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 10:00 am ET in New York.


GTx Updates Phase 2 Enobosarm Clinical Trial Results in Stress Urinary Incontinence at 2018 AUA Annual Meeting
Posted on Friday May 18, 2018

GTx, Inc. (GTXI) today released additional data supporting the durability of the response to a 12-week treatment with enobosarm 3 mg in an open-label, Phase 2 proof-of-concept clinical trial evaluating enobosarm in postmenopausal women with stress urinary incontinence (SUI). The presentation, entitled Oral Enobosarm Shows Promising Activity in Post-Menopausal Women with Stress Urinary Incontinence: Results of a Phase 2 Study, took place at the 2018 American Urological Association annual meeting being held in San Francisco, CA, from May 18 to 21, 2018. “The overall treatment effect of enobosarm in this proof-of-concept trial demonstrates the potential of enobosarm to effectively treat SUI, the most common type of incontinence suffered by women,” said Kenneth M. Peters, M.D., Chairman of Urology, Oakland University William Beaumont School of Medicine, and the principal investigator in the trial.


Does GTx Inc’s (NASDAQ:GTXI) -71.74% Earnings Drop Reflect A Longer Term Trend?
Posted on Wednesday May 16, 2018

Measuring GTx Inc’s (NASDAQ:GTXI) track record of past performance is a valuable exercise for investors. It allows us to understand whether or not the company has met or exceed expectations,Read More...


Enter a stock symbol to view the stock details.